COMPARISON OF THE EFFECTIVENESS AND COMPLICATIONS OF INFLIXIMAB AND ADALIMUMAB IN COMBO THERAPY WITH IMMUNOMODULATORS FOR CROHN'S DISEASE

(1) Medical University Of Silesia, Dept. of Gastroenterology and Hepatology, Katowice -, Poland

(2) Clinical University Central Hospital, Dept. of Gastroenterology & Hepatology, Katowice, Poland



This item was part of UEG Week 2016

This item can be cited as: United European Gastroenterology Journal; 2016: 2 (Supplement 1)